Want to join the conversation?
$DV said this acquisition represents diversification into new vertical with potential total addressable market of more than $2Bil. ACAMS is expected to generate FY17 revenue in low $40MM range. The acquisition will be modestly dilutive to EPS in FY17 and is expected to add in FY18 and beyond. The deal will be funded through cash and debt.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?